首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   29721篇
  免费   1713篇
  国内免费   299篇
耳鼻咽喉   202篇
儿科学   755篇
妇产科学   657篇
基础医学   1376篇
口腔科学   180篇
临床医学   6696篇
内科学   3844篇
皮肤病学   230篇
神经病学   1379篇
特种医学   744篇
外科学   3081篇
综合类   3586篇
预防医学   4697篇
眼科学   79篇
药学   3337篇
  44篇
中国医学   442篇
肿瘤学   404篇
  2023年   595篇
  2022年   791篇
  2021年   1294篇
  2020年   1437篇
  2019年   1250篇
  2018年   1220篇
  2017年   1110篇
  2016年   959篇
  2015年   1016篇
  2014年   2219篇
  2013年   2422篇
  2012年   2026篇
  2011年   2122篇
  2010年   1647篇
  2009年   1443篇
  2008年   1359篇
  2007年   1282篇
  2006年   1142篇
  2005年   885篇
  2004年   752篇
  2003年   628篇
  2002年   450篇
  2001年   389篇
  2000年   357篇
  1999年   310篇
  1998年   268篇
  1997年   246篇
  1996年   226篇
  1995年   278篇
  1994年   172篇
  1993年   140篇
  1992年   147篇
  1991年   146篇
  1990年   127篇
  1989年   95篇
  1988年   108篇
  1987年   83篇
  1986年   80篇
  1985年   110篇
  1984年   101篇
  1983年   59篇
  1982年   54篇
  1981年   35篇
  1980年   38篇
  1979年   26篇
  1978年   24篇
  1977年   19篇
  1976年   7篇
  1975年   13篇
  1973年   13篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
The analysis of mismatch repair proteins in solid tissue is the standard of care (SoC) for the microsatellite instability (MSI) characterization in endometrial cancer (EC). Uterine aspirates (UAs) or circulating-DNA (cfDNA) samples capture the intratumor heterogeneity and provide a more comprehensive and dynamic molecular diagnosis. Thus, MSI analysis by droplet-digital PCR (ddPCR) in UAs and cfDNA can provide a reliable tool to characterize and follow-up the disease. The UAs, paraffin-embedded tumor tissue (FFPE) and longitudinal plasma samples from a cohort of 90 EC patients were analyzed using ddPCR panel and compared to the SoC. A high concordance (96.67%) was obtained between the analysis of MSI markers in UAs and the SoC. Three discordant cases were validated as unstable by ddPCR on FFPE samples. Besides, a good overall concordance (70.27%) was obtained when comparing the performance of the ddPCR assay on UAs and cfDNA in high-risk tumors. Importantly, our results also evidenced the value of MSI analysis to monitor the disease evolution. MSI evaluation in minimally invasive samples shows great accuracy and sensitivity and provides a valuable tool for the molecular characterization and follow-up of endometrial tumors, opening new opportunities for personalized management of EC.  相似文献   
2.
3.
4.
探索重大突发公共卫生事件中以亚定点医院为代表的医疗管理模式。从上海新国际博览中心W1亚定点医院的实际运行情况出发,对其医疗供需、收治标准、运行效果、存在问题等逐一分析,结合本医疗队的经验,提出新的工作模式和管理思路。亚定点医院为普通型和有基础疾病的新冠病毒阳性感染者提供及时有效的救治,缓解了定点医院的运行压力,但也暴露出人员配置、信息化支撑、院感防控等方面的问题。采取“两级缓冲、双向转诊”的工作模式和“三个快、三个准、三个稳、三个全”的管理方案,可为患者提供及时、有效、适宜的医疗服务,缓解定点医院运行压力。  相似文献   
5.
6.
陈松  史键山 《新医学》2022,53(9):643-648
目的 探讨急诊介入栓塞治疗对于急性重度静脉曲张上消化道出血(ASVUGIB)患者的临床价值。方法 收集直接或补救介入治疗的48例ASVUGIB患者数据。按急诊介入原因分为直接介入治疗组(40例)及补救性介入治疗组(8例), 对经DSA明确造影剂外溢的直接出血征象患者行经皮经肝/经脾门静脉造影+曲张静脉栓塞术+ 经颈静脉肝内门体分流术(TIPS);对经DSA未发现明确出血征象的患者行经皮经肝/经脾门静脉造影+曲张静脉栓塞术, 术中视门静脉压力情况行经TIPS术;对于存在门-体异常分流道患者, 行球囊阻断逆行经静脉闭塞术(BRTO)+ TIPS, 治疗后随访6个月, 观察患者的临床预后。结果 直接介入治疗组患者的出血病变血管检出率为78%, 治疗有效率为78%;7 d、30 d、3个月、6个月内再出血率分别为23%、45%、45%、45%;7 d内、30 d内、3个月内、6个月内病死率分别为15%、28%、28%、28%。补救性介入治疗组患者DSA出血病变血管检出率为6/8, 治疗有效率为6/8;7 d、30 d、3个月、6个月内再出血率分别为1/8、4/8、4/8、4/8;7 d内、30 d内、3个月内、6个月内病死率分别为1/8、3/8、3/8、3/8。介入治疗后患者转氨酶、白蛋白、总胆红素和凝血功能指标均比治疗前好转(P均< 0.05), Child-Pugh评分及终末期肝病模型评分均低于治疗前(P均< 0.05)。结论 ASVUGIB是临床常见的危急症, 早发现、早干预、早治疗可改善患者预后, 介入栓塞治疗可作为存在胃镜治疗相对禁忌或胃镜治疗失败的ASVUGIB患者的治疗选择。  相似文献   
7.
IntroductionEmergency nurses experience occupational stressors resulting from exposures to critical clinical events. The purpose of this study was to identify the critical clinical events for emergency nurses serving 3 patient populations (general, adult, pediatric) and whether the resilience of these nurses differed by the patient population served.MethodsThis study used a cross-sectional survey design. A total of 48 emergency nurses were recruited from 3 trauma hospital-based emergency departments (general, adult, pediatric). Clinical Events Questionnaire, Connor-Davidson Resilience scale, and an investigator-developed demographic questionnaire were used to collect data from respondents.ResultsAll respondents were female (n = 48, 100%), and most were White (n = 46, 96%). The average age of participants was 39.6 years, the average number of years as a registered nurse was 12.7 years, and the average number of years as an emergency nurse was 8.8 years. Clinical events considered most critical were providing care to a sexually abused child, experiencing the death of a coworker, and lack of responsiveness by a colleague during a serious situation. The least stress-provoking event was incidents with excessive media coverage. Nurses were less affected by the critical events they experienced more frequently at work. Nurses in the 3 trauma settings had high level of resilience, with no statistically significant differences between groups.DiscussionThe occupational stress from exposure to significant clinical events varied with the patient population served by emergency nurses. It is important that interventions be adopted to alleviate the effect of work-related stressors and promote the psychological health of emergency nurses.  相似文献   
8.
AimThis review aims to summarize and discuss some of the most relevant clinical trials in epidemiology, diagnostics, and treatment of hypertension published in 2020 and 2021.Data synthesisThe trials included in this review are related to hypertension onset age and risk for future cardiovascular disease, reliability of different blood pressure monitoring methods, role of exercise-induced hypertension, treatment of hypertension in patients with SARS-CoV-2 infection, management of hypertension high-risk patient groups, e.g., in the elderly (≥80 years) and patients with atrial fibrillation, and the interplay between nutrition and hypertension, as well as recent insights into renal denervation for treatment of hypertension.ConclusionsHypertension onset age, nighttime blood pressure levels and a riser pattern are relevant for the prognosis of future cardiovascular diseases. The risk of coronary heart disease appears to increase linearly with increasing exercise systolic blood pressure. Renin-angiotensin system blockers are not associated with an increased risk for a severe course of COVID-19. In elderly patients, a risk-benefit assessment of intensified blood pressure control should be individually evaluated. A J-shaped association between cardiovascular disease and achieved blood pressure could also be demonstrated in patients with atrial fibrillation on anticoagulation. Salt restriction and lifestyle modification remain effective options in treating hypertensive patients at low cardiovascular risk. Sodium glucose co-transporter 2 inhibitors and Glucagon-like peptide-1 receptor agonists show BP-lowering effects. Renal denervation should be considered as an additional or alternative treatment option in selected patients with uncontrolled hypertension.  相似文献   
9.
目的 了解某国家级死因监测点居民死亡漏报情况,评价死因监测信息系统报告的完整性和准确性。 方法 某国家级死因监测点居民死亡信息来源于泸县3个抽样点。采用随机整群抽样的方法,在泸县抽取3个镇(抽样点)共42个村/社,分别从派出所、社事办、妇幼、村(居委会)等渠道收集抽样点2018—2020年全部人口死亡信息,与“人口死因监测信息管理系统”死亡报告数据进行比较,计算漏报率。对“人口死因监测信息管理系统”中抽样点居民死亡报告卡进行审核,评估死因诊断的可靠性和编码质量。 结果 泸县人群总死亡漏报率为9.38%;2018—2020年,漏报率逐渐下降,分别为18.31%、7.53%、2.16%,年度变化百分比为-11.9%,变化趋势差异有统计学意义(t=-5.175,P<0.001),抽样点死因诊断可靠性和准确性较高,可靠诊断单位占比81.81%,可靠诊断依据占比75.67%,根本死因编码错误率为0.21%。 结论 泸县死因监测数据质量较好,但仍需进一步降低漏报率,提高死因监测数据的完整性和诊断的可靠性。  相似文献   
10.
《Drug discovery today》2022,27(1):280-291
Positron emission tomography (PET) is an extensively used nuclear functional imaging technique, especially for central nervous system (CNS) and oncological disorders. Currently, drug development is a lengthy and costly pursuit. Imaging with PET radiotracers could be an effective way to hasten drug discovery and advancement, because it facilitates the monitoring of key facets, such as receptor occupancy quantification, drug biodistribution, pharmacokinetic (PK) analyses, validation of target engagement, treatment monitoring, and measurement of neurotransmitter concentrations. These parameters demand careful analyses for the robust appraisal of newly formulated drugs during preclinical and clinical trials. In this review, we discuss the usage of PET imaging in radiopharmaceutical development; drug development approaches with PET imaging; and PET developments in oncological and cardiac drug discovery.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号